Longeviti Neuro Solutions secures US patent for neurosurgical cranial implant
Click Here to Manage Email Alerts
A Maryland-based neurotechnology company has secured a U.S. patent for its novel prosthetic translucent, cranial implant intended for use during neurosurgical procedures.
In a press release, Longeviti Neuro Solutions said the ClearFit implant combines brain-computer interface capability, brain mapping and neurosonography, which permits direct communication between the brain and external devices, along with the ability for patients to interact with the technology, Longeviti said in the release.
The implant, when paired with brain-mapping capabilities, allows neurosurgeons to receive real-time, detailed anatomical images, enabling them to enhance their precision during neurological procedures. Further, the company said, integrating neurosonography within the cranial implant enables clinicians to continuously monitor brain activity during surgery in a noninvasive manner.
“This technology represents a significant advancement in the field of neurosurgery,” Longeviti Neuro Solutions CEO Jesse Christopher said in the release. “Together, Longeviti and its partners will advance neurosonography and neurosurgical patent care to significantly reduce the cost and time it takes to monitor brains anywhere in the world.”